Literature DB >> 31312893

Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease.

Andrew T Trout1,2,3, David E Hunte4, Marialena Mouzaki5,6, Stavra A Xanthakos5,6, Weizhe Su7, Bin Zhang5,8, Jonathan R Dillman4,9.   

Abstract

PURPOSE: To define the relationship between compartmental abdominal fat stores, liver and pancreatic fat fractions, and type 2 diabetes mellitus (T2DM) in children with non-alcoholic fatty liver disease (NAFLD).
METHODS: This was a retrospective study of patients with NAFLD who underwent abdominal MRI between August 2015 and July 2017. Using an axial multi-echo Dixon-based sequence, liver fat fraction (LFF) and pancreatic fat fraction (PFF) were measured. The fat image was used to quantify abdominal fat depots (thickness, cross-sectional area) at the L2 vertebral level. Multivariable models with stepwise selection were created for prediction of LFF, PFF, and T2DM status based upon variables of clinical interest.
RESULTS: 86 patients (70% male, 25% Hispanic, 58% Caucasian, 11% African American) with a mean age of 14.2 ± 3.2 years were included. 19 (22%) patients were pre-diabetic or diabetic. Only ethnicity was a predictor of LFF (P = 0.0023) with Hispanic ethnicity associated with the highest LFF. Depending on the model, either total abdominal fat area (P = 0.0003) or patient weight (P = 0.008) were the only predictors of PFF. No patient variable predicted T2DM status.
CONCLUSIONS: In our population, there was an association between ethnicity and LFF, with the highest LFF in Hispanics. The presence or severity of hepatic steatosis could not be predicted based on patient size or the distribution of abdominal fat in our cohort. Neither LFF nor PFF were predictive of T2DM.

Entities:  

Keywords:  Diabetes; MRI; NAFLD; PDFF; Pancreas; Steatosis

Year:  2019        PMID: 31312893     DOI: 10.1007/s00261-019-02123-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health.

Authors:  Antoinette A Amevor; Toshifumi Yodoshi; Andrew T Trout; Jonathan R Dillman; Ruchi Singh; Ryan Jarvis; Lin Fei; Chunyan Liu; Amy Taylor; Alexander Miethke; Marialena Mouzaki
Journal:  Liver Int       Date:  2021-11-29       Impact factor: 8.754

2.  Body composition measured by bioelectrical impedance analysis is a viable alternative to magnetic resonance imaging in children with nonalcoholic fatty liver disease.

Authors:  Sarah Orkin; Toshifumi Yodoshi; Emily Romantic; Kathryn Hitchcock; Ana Catalina Arce-Clachar; Kristin Bramlage; Qin Sun; Lin Fei; Stavra A Xanthakos; Andrew T Trout; Marialena Mouzaki
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-04-30       Impact factor: 4.016

3.  Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease.

Authors:  Toshifumi Yodoshi; Sarah Orkin; Emily Romantic; Kathryn Hitchcock; Ana-Catalina Arce Clachar; Kristin Bramlage; Qin Sun; Lin Fei; Andrew T Trout; Stavra A Xanthakos; Marialena Mouzaki
Journal:  Nutrition       Date:  2021-08-10       Impact factor: 4.893

4.  Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signaling.

Authors:  Wenjun Yang; Jinduo Zhao; Ye Zhao; Wenfeng Li; Liang Zhao; Yi Ren; Rongying Ou; Yunsheng Xu
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

Review 5.  Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.

Authors:  Ming-Ling Chang
Journal:  Biomedicines       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.